piracetam has been researched along with Cyanosis in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hamed, SA | 1 |
Elhadad, AF | 1 |
Farghaly, HS | 1 |
Maury, P | 1 |
Sacher, F | 1 |
Rollin, A | 1 |
Duparc, A | 1 |
Mondoly, P | 1 |
Probst, V | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effectiveness of Valproic Acid in Treating Frequent Cyanotic Breath Holding Spells[NCT04482764] | Phase 1 | 150 participants (Actual) | Interventional | 2017-01-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for piracetam and Cyanosis
Article | Year |
---|---|
Evaluation of the effectiveness of valproic acid for treating cyanotic breath holding spells: A Pilot prospective study.
Topics: Affect; Anticonvulsants; Breath Holding; Child, Preschool; Cyanosis; Electroencephalography; Female; | 2020 |
Ventricular fibrillation in loop recorder memories in a patient with early repolarization syndrome.
Topics: Adolescent; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cyanosis; Defibrillators, Implanta | 2012 |